Sari L Reisner, Madeline B Deutsch, Kenneth H Mayer, David R Pletta, Juwan Campbell, Jennifer Potter, Alex S Keuroghlian, Jaclyn M W Hughto, Andrew Asquith, Dana J Pardee, Alexander Harris, Meg Quint, Chris Grasso, Alex Gonzalez, Asa Radix
BACKGROUND: Transgender and gender diverse (TGD) adults in the U.S. experience health disparities, including in anogenital sexually transmitted infections (STI). Gender-affirming hormone therapy (GAHT) is known to be medically necessary and improve health. Few studies have assessed the effect of GAHT on STI diagnoses. OBJECTIVE: To evaluate the effect of GAHT delivered in primary care as an intervention to improve STI outcomes for TGD adults. DESIGN: LEGACY is a longitudinal, multisite cohort study of adult TGD primary care patients from two federally qualified community health centers in Boston, MA, and New York, NY...
November 21, 2023: Journal of General Internal Medicine